News

March 16, 2012 — Boston Scientific Corp. announced Health Canada approval of the Blazer open-irrigated catheter, the company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation (AF), atrial flutter, ventricular tachycardia and other supraventricular tachycardias.

Home March 16, 2012
Home
News

March 16, 2012 – Medistim’s VeriQ system, which uses ultrasound to assess graft blood flow during coronary artery bypass graft (CABG) surgery, recently withstood the clinical scrutiny of the English National Health Service. The VeriQ system combines ultrasound imaging and proven transit time flow measurement (TTFM) in a single system that is specifically designed for cardiovascular procedures.

Home March 16, 2012
Home
News

March 16, 2012 - Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died than non-depressed patients. The findings were independent of age, gender, clinical characteristics, anxiety and the distressed (Type D) personality.

Home March 16, 2012
Home
News

March 16, 2012 - Cambridge Heart Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that its Microvolt T-Wave Alternans (MTWA) test received reimbursement coverage from Japan’s Ministry of Health, Labor and Welfare (MHLW). Effective April 1, 2012, the MTWA Test will be reimbursed for patients who are considered at risk for lethal arrhythmias including, but not limited to, patients with a history of heart attack, cardiomyopathy and Brugada syndrome.

Home March 16, 2012
Home
News

March 16, 2012 - A technological breakthrough is allowing the University of Michigan Health System to be the first teaching hospital in the United States to perform some CT scans using a fraction of the radiation dose required for a conventional CT image.

Home March 16, 2012
Home
Feature

The Heart Rhythm Society (HRS) issued an international consensus statement on indications, techniques and outcomes of catheter and surgical ablation of atrial fibrillation (AF).

Home March 16, 2012
Home
News

March 15, 2012 — According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan, Saudi Arabia, South Africa and Turkey will reach a value of more than $460 million by 2016.

Home March 15, 2012
Home
News

March 13, 2012 — A new study by Brigham and Women’s Hospital (BWH) researchers found significant variation in the use of head computed tomography (CT) exams among doctors within the emergency department (ED).

Home March 13, 2012
Home
News

March 20, 2012 - TyRx Inc., a company specializing in the commercialization of implantable medical devices designed to help reduce surgical-site infections, announced the launch of its new patient education website, HeartDeviceInfection.com.

Home March 13, 2012
Home
News

March 13, 2012 — Asahi Kasei Corp. and Zoll Medical Corp. jointly announced that Asahi Kasei will acquire Zoll for approximately $2.21 billion.

Home March 13, 2012
Home
Technology

March 12, 2012 — Philips introduced the tactically enhanced HeartStart MRx monitor-defibrillator for emergency medical services (EMS).

Home March 12, 2012
Home
News

March 12, 2012 — A new study shows that the use of gadobenate dimeglumine, the highest relaxivity gadolinium-based contrast agent (GBCA) available for central nervous system (CNS) magnetic resonance imaging (MRI), over a high concentration MRI contrast agent may improve clinicians’ ability to visualize lesions of the brain.

Home March 12, 2012
Home
Technology

March 12, 2012 — Siemens Healthcare announced shipment of the Acuson S1000 ultrasound system, a premium ultrasound platform. The Acuson S1000 system expands access to imaging performance at a very low cost of ownership.

Home March 12, 2012
Home
News

March 9, 2012 - Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal function following serious cardiovascular events, such as heart attack and acute decompensated heart failure. The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), has awarded a $2.5 million grant to Mayo Clinic's Cardiorenal Research Laboratory to conduct the research project “Cardiovascular Peptides and Myocardial Infarction.”

Home March 09, 2012
Home
News

March 9, 2012 — Boston Scientific Corp. announced the launch of the Promus Element everolimus-eluting coronary stent system in Japan. The product was recently approved by the Ministry of Health, Labor and Welfare. It incorporates a platinum chromium (PtCr) alloy with an innovative stent design and an advanced catheter delivery system designed to provide physicians improved drug-eluting stent performance in treating patients with coronary artery disease. The company plans to begin marketing the product immediately in Japan.

Home March 09, 2012
Home
Subscribe Now